Sophia Genetics Obtains CE-IVD Mark for Bioinformatics Pipeline | GenomeWeb

NEW YORK (GenomeWeb) – Sophia Genetics said today that it has obtained the CE-IVD Mark for its next-generation sequencing bioinformatics pipeline for routine genetic testing.

The CE-IVD Mark enables the Lausanne, Switzerland-based firm to offer the pipeline in all markets accepting the CE mark in Europe, Latin America, Middle East, Africa, and Asia. Sophia said that it will also seek to obtain the CE Mark for all of the genetic tests it supports.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.